AltMountain

Biomedical Innovation Opportunities Ltd

EmergingOffshore

Biomedical Innovation Opportunities Ltd is a private investment fund based in Grand Cayman, Cayman Islands. According to its most recent Form D, filed Apr 1, 2025, it has sold $10,000,000 of interests to 1 investor since its first sale in Feb 2023. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Ian Pilgrim; Jennifer Collins; Noelle L'Heureux.

Total raised
$10,000,000Cumulative sales reported on Form D
Investors
1
First sale
Feb 27, 2023
Minimum investment
$100,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Ian Pilgrim; Jennifer Collins; Noelle L'Heureux
Latest Form D
Apr 1, 2025

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌​⁠

Raise history

$10,000,000Mar 14, 2023: $10,000,000 raisedMar 6, 2024: $10,000,000 raisedApr 1, 2025: $10,000,000 raisedMar 2023Apr 2025
FiledFilingTotal raisedInvestorsSource
Apr 1, 2025Form D/A (amendment)$10,000,0001SEC.gov ↗
Mar 6, 2024Form D/A (amendment)$10,000,0001SEC.gov ↗
Mar 14, 2023Form D$10,000,0001SEC.gov ↗

3 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 14, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Biomedical Innovation Opportunities Ltd

What is the minimum investment for Biomedical Innovation Opportunities Ltd?

According to its latest Form D, filed Apr 1, 2025, the minimum investment Biomedical Innovation Opportunities Ltd accepts from an outside investor is $100,000.

Who can invest in Biomedical Innovation Opportunities Ltd?

Biomedical Innovation Opportunities Ltd is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Biomedical Innovation Opportunities Ltd raised?

Biomedical Innovation Opportunities Ltd reports $10,000,000 sold from 1 investor on its Form D filed Apr 1, 2025. This is cumulative sales since the offering began, not current assets or performance.

Where is Biomedical Innovation Opportunities Ltd based?

Biomedical Innovation Opportunities Ltd is based in Grand Cayman, Cayman Islands.

When did Biomedical Innovation Opportunities Ltd launch?

Biomedical Innovation Opportunities Ltd reports its first sale in Feb 2023, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every private investment fund

Raised more than 43% of the 577 private investment funds based in Cayman Islands, and more than 41% of all 10,324 that report sales.

Other funds with the same team

More private investment funds in Grand Cayman

Similar-size private investment funds in Cayman Islands

All private investment funds in Cayman Islands